PainChek Appoints Karen Holzberger as New CEO
Key points
- Karen Holzberger appointed as CEO effective from 17 August 2026.
- Holzberger has 26 years of healthcare leadership in US medtech companies.
- Andy Hoggan will return to COO role after interim CEO stint.
Full summary
PainChek Ltd (ASX: PCK), a developer of an AI-powered pain assessment application, announces the appointment of Karen Holzberger as CEO, effective from 17 August 2026. Holzberger, a seasoned US MedTech leader, brings extensive experience in growing early-stage and large international medtech companies. She will focus on expanding PainChek's presence in the US and other markets. Andy Hoggan, currently Interim CEO, will resume his role as Chief Operating Officer.
Summary generated by a large language model. Please interpret with care.